Page last updated: 2024-11-08

biguanides and Demyelinating Diseases

biguanides has been researched along with Demyelinating Diseases in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research Excerpts

ExcerptRelevanceReference
"Treatment with tropisetron and granisetron markedly suppressed the clinical symptoms of EAE (p<0."5.39Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis. ( Aminian, A; Dehpour, AR; Ghazi-Khansari, M; Hassanzadeh, G; Javadi, S; Kafami, L; Mehr, SE; Noorbakhsh, F; Rahimian, R, 2013)
"Treatment with tropisetron and granisetron markedly suppressed the clinical symptoms of EAE (p<0."1.39Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis. ( Aminian, A; Dehpour, AR; Ghazi-Khansari, M; Hassanzadeh, G; Javadi, S; Kafami, L; Mehr, SE; Noorbakhsh, F; Rahimian, R, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aminian, A1
Noorbakhsh, F1
Ghazi-Khansari, M1
Kafami, L1
Javadi, S1
Hassanzadeh, G1
Rahimian, R1
Dehpour, AR1
Mehr, SE1

Other Studies

1 other study available for biguanides and Demyelinating Diseases

ArticleYear
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
    Neuroscience, 2013, Sep-17, Volume: 248

    Topics: Animals; Biguanides; Cell Proliferation; Demyelinating Diseases; Disease Models, Animal; Dose-Respon

2013